Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Marinus Pharmaceuticals (MRNS) has a market cap of $30.094 million USD. According to our data, Marinus Pharmaceuticals is ranked No.8415 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $30.09 M |
1.87%
|
| Dec 31, 2024 | $29.54 M |
-95.08%
|
| Dec 29, 2023 | $0.60 B |
173.12%
|
| Dec 30, 2022 | $0.22 B |
-66.50%
|
| Dec 31, 2021 | $0.66 B |
-2.62%
|
| Dec 31, 2020 | $0.67 B |
41.20%
|
| Dec 31, 2019 | $0.48 B |
-24.74%
|
| Dec 31, 2018 | $0.63 B |
-64.83%
|
| Dec 29, 2017 | $1.80 B |
707.92%
|
| Dec 30, 2016 | $0.22 B |
-86.78%
|
| Dec 31, 2015 | $1.69 B |
-27.72%
|
| Dec 31, 2014 | $2.33 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
 Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
 PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 Amicus Therapeutics
FOLD
|
$2.85 B |
0.000 M
|
USA
|
 Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
 Catalyst Pharmaceuticals
CPRX
|
$2.73 B |
0.000 M
|
USA
|
 Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
 Ovid Therapeutics
OVID
|
$49.92 M |
0.000 M
|
USA
|
| Market Cap | = | MRNS Stock Price | * | MRNS Shares Outstanding |
| = | $0.55 | * | 55.22 M | |
| = | $30.09 M |